Market Movers

Molina Healthcare, Inc.’s Stock Price Soars to $311.90, Registering a Robust 3.32% Increase: A Profitable Investment Opportunity

By December 4, 2024 No Comments

Molina Healthcare, Inc. (MOH)

311.90 USD +10.03 (+3.32%) Volume: 0.88M

Molina Healthcare, Inc.’s stock price has seen an impressive surge reaching $311.90, with a positive session change of +3.32%. Despite a trading volume of 0.88M and a year-to-date decrease of -13.68%, the healthcare company’s stock continues to demonstrate resilience in the market.


Latest developments on Molina Healthcare, Inc.

Investors have been closely monitoring Molina Healthcare, Inc. (NYSE:MOH) as key events unfold leading up to today’s stock price movements. Atom Investors LP recently invested $1.42 million in the company, while Verition Fund Management LLC holds a stake of $5.19 million. However, PDT Partners LLC has sold shares, and Zurcher Kantonalbank Zurich Cantonalbank also recently sold 1,850 shares. Caisse DE Depot ET Placement DU Quebec has decreased its holdings in Molina Healthcare. Analysts have given a consensus recommendation of “Hold” for the company, indicating a mixed sentiment in the market. With these developments, investors are keenly watching how Molina Healthcare‘s stock price will be affected today.


Molina Healthcare, Inc. on Smartkarma

According to analyst coverage on Smartkarma, Baptista Research has published two reports on Molina Healthcare. The first report titled “Molina Healthcare Inc.: These Are The 6 Biggest Factors Impacting Its Performance In 2025 & Beyond! – Major Drivers” highlights the company’s recent earnings report for the third quarter of 2024, showing mixed performance but with certain financial achievements. Despite facing upward pressure on medical costs, Molina Healthcare maintained a robust adjusted pre-tax margin of 4.5%. The second report, “Molina Healthcare Inc.: Initiation of Coverage – A Story Of Enhanced Focus on Managed Medicaid and Medicare Advantage Expansion! – Major Drivers,” discusses the company’s first quarter earnings, achieving an adjusted EPS of $5.73 and demonstrating strong medical cost management.


A look at Molina Healthcare, Inc. Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth4
Resilience4
Momentum3
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Molina Healthcare shows a promising long-term outlook. With high scores in Growth and Resilience, the company is well-positioned to expand and withstand potential challenges in the healthcare industry. This indicates that Molina Healthcare has the potential for sustainable growth and the ability to adapt to changing market conditions.

However, the low score in Dividend suggests that investors looking for regular income may not find Molina Healthcare to be a suitable option. Despite this, the overall positive outlook with solid scores in Value and Momentum makes Molina Healthcare a company worth keeping an eye on for investors seeking growth opportunities in the healthcare sector.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars